News Column

New Nanoparticles Study Findings Have Been Reported by Investigators at University of Kalyani

February 14, 2014

By a News Reporter-Staff News Editor at Drug Week -- New research on Nanoparticles is the subject of a report. According to news originating from Bengal, India, by NewsRx correspondents, research stated, "The development of eco-friendly technologies in material synthesis is of considerable importance to expand their biological applications."

Our news journalists obtained a quote from the research from the University of Kalyani, "Nowadays, a variety of green nanoparticles with well-defined chemical composition, size, and morphology have been synthesized by different methods and their applications in many cutting-edge technological areas have been explored. This review highlights the classification of nanoparticles giving special emphasis on biosynthesis of metal nanoparticle by viable organisms."

According to the news editors, the research concluded: "It also focuses on the applications of these biosynthesized nanoparticles in a wide spectrum of potential areas of medical biology including catalysis, targeted drug delivery, cancer treatment, antibacterial agents and as biosensors."

For more information on this research see: Green nanotechnology - A new hope for medical biology. Environmental Toxicology and Pharmacology, 2013;36(3):997-1014. Environmental Toxicology and Pharmacology can be contacted at: Elsevier Science Bv, PO Box 211, 1000 Ae Amsterdam, Netherlands. (Elsevier -; Environmental Toxicology and Pharmacology -

The news correspondents report that additional information may be obtained from D. Nath, University of Kalyani, Dept. of Zool, Cytogenet & Mol Biol Lab, Nadia, W Bengal, India (see also Nanoparticles).

Keywords for this news article include: Asia, India, Bengal, Nanotechnology, Emerging Technologies

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Drug Week

Story Tools